DRUG DISCOVERY SOLUTIONS

Posts Tagged ‘Venomtech’

Venomtech and Mibelle Biochemistry announce the launch of soothing venom peptide for sensitive skin preparations 

A novel active ingredient inspired by nature from under the sea In the never-ending search for interesting new sources for active ingredients, much of the attention these days has shifted towards ingredients of marine origin. Many marine species have not yet been extensively studied. This makes new findings that propose beneficial effects for us highly…

Read More

Venomtech’s new BD Director

We are pleased to introduce the newest recruit – Dr Paul Grant. Paul Joins us with a long history in both pharmaceutical sales and neuroscience, an exciting addition to our team. See his LinkedIn profile for more info – https://uk.linkedin.com/in/paul-grant-ab3a5812    

Read More

Venom peptide antimicrobial action

Following on from our inclusion in Sky News report on the need for new antibiotics we thought we’d show you some of our venom in action. This plate was dosed with one of our snake venoms specifically chosen by our scientists. The bacteria growing in a lawn are Staphylococcus albus which are clearly killed in…

Read More

Happy Birthday to Venomtech

We are excited to announce we are six years old. During those six years we have moved through three locations each time getting bigger and better. Now located in the amazing Discovery Park Community. We have shipped venoms to customers far and wide (USA, Europe, India and Australia). But most importantly we have facilitated work…

Read More

Proudly Supporting World Pancreatic Cancer Day

Venomtech are proudly supporting World Pancreatic Cancer day in the best way we feel has the most impact. Interviewing potential PhD students for our joint project to combat this devastating disease with Canterbury Christ Church University CCCU news link. There are many challenges with Pancreatic cancer stemming from the lack of understanding of the disease,…

Read More

What is all the excitement about scorpion venoms?

Scorpions are an ancient group of arthropods who have evolved venom to subdue other invertebrates and even as an aphrodisiac in courtship. This potent cocktail of proteins peptides and other bio-molecules represents a wealth of new chemcial matter for drug discovery. As a result two of the top ten articles published in Toxicon are devoted…

Read More

Investment opportunity through SyndicateRoom

Venomtech have launched the last stage of their funding program with SyndicateRoom. Venomtech®, the United Kingdom’s only commercial venom supplier, and SyndicateRoom, one of the UK’s leading online equity crowdfunding platform, today announced the launch of Venomtech’s funding round. This partnership leverages the SyndicateRoom’s FCA regulated investment vehicle with the opportunity to be part of Venomtech’s…

Read More

Need novel analgesics?

Once more the theraphosids (Tarantulas) have delivered novel tools for targeting pain relevant ion channels. A novel NaV1.7 blocking peptide has been identified from the species Grammostolla porteri (pictured). This peptide has 1000x fold selectivity over NaV1.5 and 20x over NaV1.4. However mutational analysis and structural analysis has allowed for modification to increase the NaV1.4…

Read More

Sicarius terrosus venom

Sicarius terrosus (six-eyed cave spider) is a highly toxic (and somewhat infamous) spider of the sicariidae family, whose bites, however rare, are characterised by significant necrotic pathology and potential mortality.  This is largely because of the presence of sphingomyelinase D in its venom[1], in the form of Phospholipase D StSicTox-betaIC1[2].  This has been shown to…

Read More